192 related articles for article (PubMed ID: 28420987)
1. Curcumin Ameliorates Cisplatin-Induced Nephrotoxicity and Potentiates Its Anticancer Activity in SD Rats: Potential Role of Curcumin in Breast Cancer Chemotherapy.
Kumar P; Barua CC; Sulakhiya K; Sharma RK
Front Pharmacol; 2017; 8():132. PubMed ID: 28420987
[TBL] [Abstract][Full Text] [Related]
2. Rosiglitazone synergizes anticancer activity of cisplatin and reduces its nephrotoxicity in 7, 12-dimethyl benz{a}anthracene (DMBA) induced breast cancer rats.
Tikoo K; Kumar P; Gupta J
BMC Cancer; 2009 Apr; 9():107. PubMed ID: 19356226
[TBL] [Abstract][Full Text] [Related]
3. Nordihydroguaiaretic acid ameliorates cisplatin induced nephrotoxicity and potentiates its anti-tumor activity in DMBA induced breast cancer in female Sprague-Dawley rats.
Mundhe NA; Kumar P; Ahmed S; Jamdade V; Mundhe S; Lahkar M
Int Immunopharmacol; 2015 Sep; 28(1):634-42. PubMed ID: 26247680
[TBL] [Abstract][Full Text] [Related]
4. Comparative nephroprotective effects of curcumin and etoricoxib against cisplatin-induced acute kidney injury in rats.
Abd El-Kader M; Taha RI
Acta Histochem; 2020 May; 122(4):151534. PubMed ID: 32151374
[TBL] [Abstract][Full Text] [Related]
5. TNF-α, IL-6 and IL-10 expressions, responsible for disparity in action of curcumin against cisplatin-induced nephrotoxicity in rats.
Kumar P; Sulakhiya K; Barua CC; Mundhe N
Mol Cell Biochem; 2017 Jul; 431(1-2):113-122. PubMed ID: 28258441
[TBL] [Abstract][Full Text] [Related]
6. Thymoquinone and curcumin combination protects cisplatin-induced kidney injury, nephrotoxicity by attenuating NFκB, KIM-1 and ameliorating Nrf2/HO-1 signalling.
Al Fayi M; Otifi H; Alshyarba M; Dera AA; Rajagopalan P
J Drug Target; 2020 Nov; 28(9):913-922. PubMed ID: 31983246
[TBL] [Abstract][Full Text] [Related]
7. Raloxifene Inhibits NF-kB Pathway and Potentiates Anti-Tumour Activity of Cisplatin with Simultaneous Reduction in its Nephrotoxictiy.
Jamdade VS; Mundhe NA; Kumar P; Tadla V; Lahkar M
Pathol Oncol Res; 2016 Jan; 22(1):145-53. PubMed ID: 26439246
[TBL] [Abstract][Full Text] [Related]
8. Curcumin nanoparticles ameliorate hepatotoxicity and nephrotoxicity induced by cisplatin in rats.
El-Gizawy MM; Hosny EN; Mourad HH; Abd-El Razik AN
Naunyn Schmiedebergs Arch Pharmacol; 2020 Oct; 393(10):1941-1953. PubMed ID: 32447466
[TBL] [Abstract][Full Text] [Related]
9. 5-Azacytidine prevents cisplatin induced nephrotoxicity and potentiates anticancer activity of cisplatin by involving inhibition of metallothionein, pAKT and DNMT1 expression in chemical induced cancer rats.
Tikoo K; Ali IY; Gupta J; Gupta C
Toxicol Lett; 2009 Dec; 191(2-3):158-66. PubMed ID: 19723570
[TBL] [Abstract][Full Text] [Related]
10. Diallyl sulfide alleviates cisplatin-induced nephrotoxicity in rats via suppressing NF-κB downstream inflammatory proteins and p53/Puma signalling pathway.
Elkhoely A; Kamel R
Clin Exp Pharmacol Physiol; 2018 Jun; 45(6):591-601. PubMed ID: 29266336
[TBL] [Abstract][Full Text] [Related]
11. Curcumin counteracts cisplatin-induced nephrotoxicity by preventing renal tubular cell apoptosis.
Topcu-Tarladacalisir Y; Sapmaz-Metin M; Karaca T
Ren Fail; 2016 Nov; 38(10):1741-1748. PubMed ID: 27758164
[TBL] [Abstract][Full Text] [Related]
12. Wogonin pre-treatment attenuates cisplatin-induced nephrotoxicity in rats: Impact on PPAR-γ, inflammation, apoptosis and Wnt/β-catenin pathway.
Badawy AM; El-Naga RN; Gad AM; Tadros MG; Fawzy HM
Chem Biol Interact; 2019 Aug; 308():137-146. PubMed ID: 31103702
[TBL] [Abstract][Full Text] [Related]
13. Tetramethylpyrazine guards against cisplatin-induced nephrotoxicity in rats through inhibiting HMGB1/TLR4/NF-κB and activating Nrf2 and PPAR-γ signaling pathways.
Michel HE; Menze ET
Eur J Pharmacol; 2019 Aug; 857():172422. PubMed ID: 31152701
[TBL] [Abstract][Full Text] [Related]
14. Effect of concomitant treatment of curcumin and melatonin on cisplatin-induced nephrotoxicity in rats.
Ali BH; Abdelrahman A; Al Suleimani Y; Manoj P; Ali H; Nemmar A; Al Za'abi M
Biomed Pharmacother; 2020 Nov; 131():110761. PubMed ID: 33152924
[TBL] [Abstract][Full Text] [Related]
15. 5-Aminolevulinic acid protects against cisplatin-induced nephrotoxicity without compromising the anticancer efficiency of cisplatin in rats in vitro and in vivo.
Terada Y; Inoue K; Matsumoto T; Ishihara M; Hamada K; Shimamura Y; Ogata K; Inoue K; Taniguchi Y; Horino T; Karashima T; Tamura K; Fukuhara H; Fujimoto S; Tsuda M; Shuin T
PLoS One; 2013; 8(12):e80850. PubMed ID: 24324635
[TBL] [Abstract][Full Text] [Related]
16. Benzbromarone mitigates cisplatin nephrotoxicity involving enhanced peroxisome proliferator-activated receptor-alpha (PPAR-α) expression.
Abdel-Razek EA; Abo-Youssef AM; Azouz AA
Life Sci; 2020 Feb; 243():117272. PubMed ID: 31926251
[TBL] [Abstract][Full Text] [Related]
17. Curcumin Acts as a Chemosensitizer for Leiomyosarcoma Cells In Vitro But Fails to Mediate Antioxidant Enzyme Activity in Cisplatin-Induced Experimental Nephrotoxicity in Rats.
Dhima I; Zerikiotis S; Lekkas P; Simos YV; Gkiouli M; Vezyraki P; Dounousi E; Ragos V; Giannakopoulos X; Baltogiannis D; Kalfakakou V; Evangelou A; Peschos D; Karkabounas S
Integr Cancer Ther; 2019; 18():1534735419872811. PubMed ID: 31441361
[No Abstract] [Full Text] [Related]
18. Novel insights into the augmented effect of curcumin and liraglutide in ameliorating cisplatin-induced nephrotoxicity in rats: Effects on oxidative stress, inflammation, apoptosis and pyroptosis via GSK-3β.
El-Gohary RM; Ghalwash AA; Awad MM; El-Shaer RAA; Ibrahim S; Eltantawy AF; Elmansy A; Okasha AH
Arch Biochem Biophys; 2023 Nov; 749():109801. PubMed ID: 37884117
[TBL] [Abstract][Full Text] [Related]
19. Curcumin inhibits angiotensin II-induced inflammation and proliferation of rat vascular smooth muscle cells by elevating PPAR-γ activity and reducing oxidative stress.
Li HY; Yang M; Li Z; Meng Z
Int J Mol Med; 2017 May; 39(5):1307-1316. PubMed ID: 28339005
[TBL] [Abstract][Full Text] [Related]
20. Curcumin delays development of medroxyprogesterone acetate-accelerated 7,12-dimethylbenz[a]anthracene-induced mammary tumors.
Carroll CE; Benakanakere I; Besch-Williford C; Ellersieck MR; Hyder SM
Menopause; 2010; 17(1):178-84. PubMed ID: 19629015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
